dendrophenol has been researched along with gambogic acid in 1 studies
Studies (dendrophenol) | Trials (dendrophenol) | Recent Studies (post-2010) (dendrophenol) | Studies (gambogic acid) | Trials (gambogic acid) | Recent Studies (post-2010) (gambogic acid) |
---|---|---|---|---|---|
37 | 0 | 22 | 348 | 1 | 260 |
Protein | Taxonomy | dendrophenol (IC50) | gambogic acid (IC50) |
---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 3.07 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 0.47 | |
Regulator of G-protein signaling 17 | Homo sapiens (human) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, F; Gao, J; Guan, L; Lin, Q; Liu, B; Liu, W; Qu, W; Zhang, J; Zhang, Y; Zhou, J; Zhu, H | 1 |
1 other study(ies) available for dendrophenol and gambogic acid
Article | Year |
---|---|
Design, synthesis and antitumour and anti-angiogenesis evaluation of 22 moscatilin derivatives.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzyl Compounds; Binding Sites; Cell Proliferation; Down-Regulation; Drug Design; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Molecular Docking Simulation; Neovascularization, Physiologic; Protein Structure, Tertiary; Tubulin; Zebrafish | 2019 |